Your session is about to expire
← Back to Search
Topotecan Hydrochloride for Bladder Carcinoma
Study Summary
This trial tests if a combo of M6620+topotecan can better shrink small cell lung/extrapulmonary cancer than topotecan alone.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 3 trial • 4312 Patients • NCT00011986Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How have safety assessments for Topotecan Hydrochloride been evaluated?
"Drawing from clinical evidence, we can safely say that Topotecan Hydrochloride is relatively secure and thus merits a score of 2 on our safety scale. This drug has successfully passed Phase 2 trials but efficacy data remains inconclusive."
Could you provide an overview of the existing research regarding Topotecan Hydrochloride?
"Topotecan Hydrochloride was first investigated in 2005 at St. Jude Children's Research Hospital and has since seen a total of 226 completed studies, 69 of which are still active, predominantly located in Wilkesboro, Kansas."
What conditions typically respond to treatment with Topotecan Hydrochloride?
"Topotecan Hydrochloride is a medication often prescribed to treat ovarian cancer. It can also be utilized as an effective remedy for acute myeloid leukemia, sarcoma, and other malignant neoplasms."
What is the geographic scope of this research experiment?
"At the moment, 32 medical centres are recruiting for this clinical trial. Examples of cities included in these sites include Wilkesboro, Salina and Bethesda. If you plan to participate it is recommended that you choose a location nearest to your residence in order to reduce transportation costs associated with the study."
Is this trial actively looking for participants now?
"At this moment, no new participants are being accepted for the clinical trial. The study was first published on August 23rd 2019 and underwent its latest update on February 18th 2023. If you're searching for other medical trials, 2734 studies enrolling patients with extensive stage small cell lung cancer and 69 Topotecan Hydrochloride related investigations are actively recruiting volunteers."
What is the upper limit of participants taking part in this investigation?
"This trial is currently not accepting applicants. It was first published on August 23, 2019 and last edited February 18, 2023. If you are looking for other medical trials to join, there are 2734 different studies with extensive stage small cell lung cancer and 69 separate trials involving topotecan hydrochloride now actively enrolling patients."
Share this study with friends
Copy Link
Messenger